Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simona Soverini

Showing results (31-40 of 162) with videos related to

Pageof 17
Sort By:
Haematologica|March 7, 2007
Monitoring BCR-ABL transcript levels by real-time quantitative polymerase chain reaction: a linear regression equation to convert from BCR-ABL/B2M ratio to estimated BCR-ABL/ABL ratioIlaria Iacobucci, Livia Galletti, Marilina Amabile, et al.
International Journal of Molecular Sciences|July 2, 2021
The Role of Hypoxic Bone Marrow Microenvironment in Acute Myeloid Leukemia and Future Therapeutic OpportunitiesSamantha Bruno, Manuela Mancini, Sara De Santis, et al.
Leukemia Research|April 15, 2011
F317L BCR-ABL1 kinase domain mutation associated with a sustained major molecular response in a CML patient on dasatinibAnthony A Oyekunle, Fausto Castagnetti, Gabriele Gugliotta, et al.
Mediterranean Journal of Hematology and Infectious Diseases|July 19, 2021
Systemic Mastocytosis: Molecular Landscape and Implications for TreatmentCecilia Monaldi, Sara De Santis, Manuela Mancini, et al.
Oncotargets and Therapy|February 4, 2022
Overcoming Resistance to Kinase Inhibitors: The Paradigm of Chronic Myeloid LeukemiaSara De Santis, Cecilia Monaldi, Manuela Mancini, et al.
FEBS Letters|November 12, 2009
c-Abl and Src-family kinases cross-talk in regulation of myeloid cell migrationAnna Baruzzi, Ilaria Iacobucci, Simona Soverini, et al.
Expert Review of Hematology|November 19, 2010
New mechanisms of resistance in Philadelphia chromosome acute lymphoblastic leukemiaGiovanni Martinelli, Ilaria Iacobucci, Simona Soverini, et al.
Hematological Oncology|September 22, 2006
Monitoring minimal residual disease and controlling drug resistance in chronic myeloid leukaemia patients in treatment with imatinib as a guide to clinical managementGiovanni Martinelli, Ilaria Iacobucci, Simona Soverini, et al.
Biologics : Targets & Therapy|August 27, 2009
Nilotinib: a novel encouraging therapeutic option for chronic myeloid leukemia patients with imatinib resistance or intoleranceGiovanni Martinelli, Ilaria Iacobucci, Simona Soverini, et al.
Leukemia|January 25, 2019
The proportion of different BCR-ABL1 transcript types in chronic myeloid leukemia. An international overviewMichele Baccarani, Fausto Castagnetti, Gabriele Gugliotta, et al.
Pageof 17

Showing results (31-40 of 162) with videos related to

Sort By:
Pageof 17
Haematologica|March 7, 2007
Monitoring BCR-ABL transcript levels by real-time quantitative polymerase chain reaction: a linear regression equation to convert from BCR-ABL/B2M ratio to estimated BCR-ABL/ABL ratioIlaria Iacobucci, Livia Galletti, Marilina Amabile, et al.
International Journal of Molecular Sciences|July 2, 2021
The Role of Hypoxic Bone Marrow Microenvironment in Acute Myeloid Leukemia and Future Therapeutic OpportunitiesSamantha Bruno, Manuela Mancini, Sara De Santis, et al.
Leukemia Research|April 15, 2011
F317L BCR-ABL1 kinase domain mutation associated with a sustained major molecular response in a CML patient on dasatinibAnthony A Oyekunle, Fausto Castagnetti, Gabriele Gugliotta, et al.
Mediterranean Journal of Hematology and Infectious Diseases|July 19, 2021
Systemic Mastocytosis: Molecular Landscape and Implications for TreatmentCecilia Monaldi, Sara De Santis, Manuela Mancini, et al.
Oncotargets and Therapy|February 4, 2022
Overcoming Resistance to Kinase Inhibitors: The Paradigm of Chronic Myeloid LeukemiaSara De Santis, Cecilia Monaldi, Manuela Mancini, et al.
FEBS Letters|November 12, 2009
c-Abl and Src-family kinases cross-talk in regulation of myeloid cell migrationAnna Baruzzi, Ilaria Iacobucci, Simona Soverini, et al.
Expert Review of Hematology|November 19, 2010
New mechanisms of resistance in Philadelphia chromosome acute lymphoblastic leukemiaGiovanni Martinelli, Ilaria Iacobucci, Simona Soverini, et al.
Hematological Oncology|September 22, 2006
Monitoring minimal residual disease and controlling drug resistance in chronic myeloid leukaemia patients in treatment with imatinib as a guide to clinical managementGiovanni Martinelli, Ilaria Iacobucci, Simona Soverini, et al.
Biologics : Targets & Therapy|August 27, 2009
Nilotinib: a novel encouraging therapeutic option for chronic myeloid leukemia patients with imatinib resistance or intoleranceGiovanni Martinelli, Ilaria Iacobucci, Simona Soverini, et al.
Leukemia|January 25, 2019
The proportion of different BCR-ABL1 transcript types in chronic myeloid leukemia. An international overviewMichele Baccarani, Fausto Castagnetti, Gabriele Gugliotta, et al.
Pageof 17